Combined Carboplatin plus Ifosfamide and Cisplatin in Patients with Advanced Ovarian Carcinoma. A Phase I-II Study

By Lorusso V.   Leone B.   Di Vagno G.   Manzione L.   Palmeri S.   Vallejo C.   Machiavelli M.   Nacci G.   Bilancia D.   Leonardi V.   Catino A.   Gargano G.   Loverro G.   Selvaggi L.   De Lena M.  

Gynecologic Oncology, Vol. 68, Iss. 2, 1998-02 ,pp. : 172-177

Elsevier

Access to resources Recommend Favorite

A Phase II Study of Intraperitoneal Cisplatin and Thiotepa in Residual Ovarian Carcinoma: A Gynecologic Oncology Group Study

By Feun L.G.   Blessing J.A.   Major F.J.   DiSaia P.J.   Alvarez R.D.   Berek J.S.  

Gynecologic Oncology, Vol. 71, Iss. 3, 1998-12 ,pp. : 410-415

Elsevier

Access to resources Recommend Favorite

Intraperitoneal Mitoxantrone or Floxuridine: Effects on Time-to-Failure and Survival in Patients with Minimal Residual Ovarian Cancer after Second-Look Laparotomy-A Randomized Phase II Study by the Southwest Oncology Group

By Muggia F.M.   Liu P.Y.   Alberts D.S.   Wallace D.L.   O'Toole R.V.   Terada K.Y.   Franklin E.W.   Herrer G.W.   Goldberg D.A.   Hannigan E.V.  

Gynecologic Oncology, Vol. 61, Iss. 3, 1996-06 ,pp. : 395-402

Academic Press

Access to resources Recommend Favorite

A Phase I/II Study of Topotecan in Combination with Carboplatin in Recurrent Epithelial Ovarian Cancer

By Bolis G.   Scarfone G.   Sciatta C.   Polverino G.P.   Rosa C.   Guarnerio P.   Parazzini F.  

Gynecologic Oncology, Vol. 83, Iss. 3, 2001-12 ,pp. : 477-480

Elsevier

Access to resources Recommend Favorite

Intraperitoneal Radioimmunotherapy of Ovarian Cancer with 177 Lu-CC49: A Phase I/II Study

By Alvarez R.D.   Partridge E.E.   Khazaeli M.B.   Plott G.   Austin M.   Kilgore L.   Russell C.D.   Liu T.   Grizzle W.E.   Schlom J.   LoBuglio A.F.   Meredith R.F.  

Gynecologic Oncology, Vol. 65, Iss. 1, 1997-04 ,pp. : 94-101

Elsevier

Access to resources Recommend Favorite